Purchase of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Consumables

Authority: NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) (Central government)

GoodsAward procedure without prior publication of a call for competition

Sectors: Medical Devices & Pharma (33) Delivery: Wales (UKL22)

Awarded value£56,000published contract · exc. VAT

Awarded 30 Sept 2024no call for competition

Awarded to GAMIDA SA

What is being bought

Published requirement description

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is a type of hyperthermia therapy used in combination with surgery in the treatment of advanced abdominal cancers. The Cardiff and Vale University Health Board completed an open tender procedure in 2022, to purchase the consumables, kit and maintenance required to complete HIPEC and has since received additional funding to continue the treatment process over the next 2 years. Without the repurchase of consumables, the service cannot continue, subsequently, the Health Board would need to send patients elsewhere for treatment.

CPV: Medical consumables

The lotProcurement structure

single lot · no lot value published

Lot #1

Delivery: Wales

33140000 Medical consumables

Procedure terms & legal framework

From the official record · publisher note attached

Procedure method: Award procedure without prior publication of a call for competition
Legal basis: CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category: Goods
Notice status: Awarded without competition
Procurement threshold: Unspecified in notice
Regulatory regime: Standard
Commercial structure: Stand-alone contract (no framework)
Competition type: Direct award (no call for competition)
GPA / WTO covered: Yes (GPA)
Recurring procurement: Unspecified in notice
First published: 7 Oct 2024, 15:38 BST
Last source update: 7 Oct 2024, 15:38 BST
FTS notice number: 2024/S 000-032102
Classification (CPV): Medical consumables
Delivery area: Wales (UKL22)
Official registry OCID: ocds-h6vhtk-04a66f Find a Tender

Why no open competition: The procurement falls outside the scope of application of the directive
Published justification: The original tender was awarded to Gamida LTD after the trial of multiple different supplier’s kit and consumables. The kit was purchased soon after from Gamida LTD. Now that the Health Board has received further funding for HIPEC treatment, there is a need to repurchase the necessary consumables from Gamida LTD to continue the service and treat patients, utilising the current equipment purchased as a result of the tender process.
For a continuity of service, the Health Board are direct awarding to Gamida LTD to continue providing the necessary treatment and service to patients.

Publisher note: NOTE: To register your interest in this notice and obtain any additional information please visit the Sell2Wales Web Site at https://www.sell2wales.gov.wales/Search/Search_Switch.aspx?ID=144888. (WA Ref:144888)

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast

Awards 1

Awarded value £56,0001 contract exc. VAT

Contracts signed 1latest 30 Sept 2024

Awarded to	Value	Date	Status
GAMIDA SA	£56,000 †	—	Awarded

Contracts

Contract 032102-2024-1 · GAMIDA SA
Signed
30 Sept 2024
Value
£56,000
Status
active

Contracting authority & participating public bodies

NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)

Contracting authorityCentral GovernmentRegional or local authorityHealth Woodland House, Maes YCoed Road, Cardiff, UK, CF15 7QZContact name, email

Dispute resolution & review bodies

High CourtReview body LondonContact phone

Bidders & participating suppliers

1 commercial party on the notice

GAMIDA SAAwarded supplier 31 rue des alouettes, Eaubonne, FR10, 95600

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.